The Hepatic sinusoidal obstruction syndrome (HSOS), also known as veno-occlusive disease (VOD), is a well-known complication of haematopoietic stem cell transplantation, of the treatment of Wilms tumor and rhabdomyosarcoma and maintenance therapy of acute lymphoblastic leukemias. Its occurrence is rare in other cancers of the child. We report the observation of a 7-year-old girl with Burkitt's lymphoma who developed a severe HSOS during her second induction treatment with dexamethasone, cisplatin, cytosine arabinoside. The evolution was fatal. This observation shows that the diagnosis of HSOS should not be excluded in the absence of the risk factors usually described.
Introduction
The serous hepatosis or Hepatic sinusoidal obstruction syndrome (HSOS) is due to an occlusion of the terminal hepatic venules and hepatic sinusoids. It is characterized clinically by painful hepatomegaly, hyper bilirubinemia and/or jaundice and rapid weight gain in relation to hydro-sodium retention. This frequent complication of transplantation of hematopoietic stem cells is also described during the chemotherapy of nephroblastoma and rhabdomyosarcoma. This syndrome is rare in conventional chemotherapy and in other childhood cancers [1] [2] [3] . We report the observation of a 7-year-old girl who developed Open Journal of Blood Diseases a severe VOD during the treatment of Burkitt's lymphoma. [9]. This syndrome is also a common complication of the treatment of acute lymphoblastic leukemia using 6-thioguanine [10] , whereas only isolated cases have been reported during the induction treatment of leukemia [11] [12] . The SOS has been described in series of children with an autograft of hematopoietic stem cells for malignant lymphomas [13] , but it is very rare during conventional lymphoma chemotherapy. We report to our knowledge the second fatal case of VOD during the induction of lymphoma. The first case published by Yamamoto and Al is that of an overweight 9-year-old child who presented central nervous system lymphoma treated with Vincristine, Cyclophosphamide, Daunorubicin, L-Asparaginase. The causal agent identified was vincristine, the risk factors for death were severity of VOD and the overweight [3] . In our case the drugs re-Open Journal of Blood Diseases ceived were Cytosine Arabinoside high dose, Cisplatin and dexamethasone. Our case emphasizes the appearance of SOS outside the usual framework described.
Case Report
The anti-cancer drugs may have variable liver toxicity ranging from elevated transaminases to life-threatening hepatic necrosis [14] . The hepatic lesions occurring during cancer treatment may result from the combined action of anticancer agents, antibiotics, antiemetics, analgesics or other drugs. The pre-existing medical problems (hepatitis, other infections, nutritional deficiencies and parenteral nutrition) may influence the response of the host to drug toxicity [15] . The SOS may result from the use of specific anti-cancer combinations [2] . Kotécha et al. 
Conclusion
We described the observation of a child with Burkitt's lymphoma who developed a fatal SOS during induction chemotherapy. This observation shows that the diagnosis of VOD should not be excluded in the absence of the risk factors usually described.
